Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+7.21%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$93.6B
AUM Growth
+$11.5B
(+14%)
Cap. Flow
+$6.53B
Cap. Flow
% of AUM
6.98%
Top 10 Holdings %
Top 10 Hldgs %
30.05%
Holding
1,605
New
33
Increased
702
Reduced
242
Closed
12
Top Buys
| 1 |
CME Group
CME
|
+$546M |
| 2 |
Apple
AAPL
|
+$519M |
| 3 |
Booking.com
BKNG
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$401M |
| 5 |
AutoZone
AZO
|
+$325M |
Top Sells
| 1 |
Danaher
DHR
|
+$369M |
| 2 |
Moody's
MCO
|
+$173M |
| 3 |
Philip Morris
PM
|
+$160M |
| 4 |
Accenture
ACN
|
+$140M |
| 5 |
Equifax
EFX
|
+$131M |
Sector Composition
| 1 | Technology | 30.78% |
| 2 | Financials | 14.09% |
| 3 | Healthcare | 13.56% |
| 4 | Consumer Discretionary | 9.66% |
| 5 | Communication Services | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Sarepta Therapeutics
SRPT
$1.81B
| $273K | ﹤0.01% |
2,186
-193
| -8% | -$24.1K |
|
|
LAND
927
Gladstone Land Corp
LAND
$320M
| $270K | ﹤0.01% |
19,400
| – | – |
|
|
CLDT
928
Chatham Lodging
CLDT
$348M
| $265K | ﹤0.01% |
31,108
| – | – |
|
|
OLP
929
One Liberty Properties
OLP
$492M
| $265K | ﹤0.01% |
9,618
| – | – |
|
930
HDFC Bank
HDB
$180B
| $263K | ﹤0.01% |
4,197
-374
| -8% | -$23.4K |
|
931
Beam Therapeutics
BEAM
$2.01B
| $260K | ﹤0.01% |
10,608
-1,002
| -9% | -$24.5K |
|
932
OmniAb
OABI
$225M
| $258K | ﹤0.01% |
60,896
-5,752
| -9% | -$24.3K |
|
|
CAN
933
Canaan Creative
CAN
$345M
| $256K | ﹤0.01% |
253,419
+81,272
| +47% | +$82.1K |
|
934
Q2 Holdings
QTWO
$5.17B
| $256K | ﹤0.01% |
3,208
-73
| -2% | -$5.82K |
|
|
GOEV
935
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $251K | ﹤0.01% |
12,767
-485
| -4% | -$9.54K |
|
936
Neurogene
NGNE
$266M
| $250K | ﹤0.01% |
5,956
-563
| -9% | -$23.6K |
|
937
Fate Therapeutics
FATE
$115M
| $249K | ﹤0.01% |
71,101
-6,715
| -9% | -$23.5K |
|
938
Accuray
ARAY
$174M
| $249K | ﹤0.01% |
138,205
+2,611
| +2% | +$4.7K |
|
|
CBL
939
CBL Properties
CBL
$985M
| $247K | ﹤0.01% |
9,803
-6,562
| -40% | -$165K |
|
|
AUTL
940
Autolus Therapeutics
AUTL
$362M
| $247K | ﹤0.01% |
67,979
-6,419
| -9% | -$23.3K |
|
941
Iovance Biotherapeutics
IOVA
$836M
| $239K | ﹤0.01% |
25,492
-2,407
| -9% | -$22.6K |
|
|
CTO
942
CTO Realty Growth
CTO
$559M
| $237K | ﹤0.01% |
12,449
| – | – |
|
943
CureVac
CVAC
$1.21B
| $235K | ﹤0.01% |
79,962
-7,552
| -9% | -$22.2K |
|
944
LendingClub
LC
$1.87B
| $233K | ﹤0.01% |
20,367
-505
| -2% | -$5.77K |
|
945
Xencor
XNCR
$597M
| $230K | ﹤0.01% |
11,437
-1,045
| -8% | -$21K |
|
|
VERV
946
DELISTED
Verve Therapeutics
VERV
| $230K | ﹤0.01% |
47,488
-4,483
| -9% | -$21.7K |
|
947
CRISPR Therapeutics
CRSP
$4.73B
| $229K | ﹤0.01% |
4,880
-454
| -9% | -$21.3K |
|
948
Rocket Companies
RKT
$43.7B
| $227K | ﹤0.01% |
11,845
-294
| -2% | -$5.64K |
|
949
Bit Digital
BTBT
$945M
| $226K | ﹤0.01% |
64,372
-1,597
| -2% | -$5.61K |
|
|
SMAR
950
DELISTED
Smartsheet Inc.
SMAR
| $225K | ﹤0.01% |
4,068
| – | – |
|